Patent · US Active

Targeting kinases for the treatment of cancer metastasis

US11406643B2 · kind B2 · utility

1Cited by
5References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 10, 2018
Grant dateAug 9, 2022
Priority date
Expiry dateAug 10, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are methods for the treatment of brain metastasis by administering a kinase inhibitor targeted to a metastasis-promoting kinase identified by an in vivo kinase screen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.